Skip to content
lifestyle.thedishh.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
R1 Therapeutics
R1 Therapeutics expands Series A to $80.5 million to advance global Phase 2b program in hyperphosphatemia
September 30, 2026